These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2748555)

  • 41. [Treatment of bronchial tuberculosis, complicating bronchoadenitis].
    Shesterina MV; Kim ACh
    Probl Tuberk; 1973; 51(12):19-22. PubMed ID: 4782094
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients.
    Seyedrezazadeh E; Ostadrahimi A; Mahboob S; Assadi Y; Ghaemmagami J; Pourmogaddam M
    Respirology; 2008 Mar; 13(2):294-8. PubMed ID: 18339032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biochemical basis of use of pathogenetic therapy in pulmonary tuberculosis].
    Gur'eva IG; Andrzheiuk NI; Smirnova NA
    Probl Tuberk; 1978 Nov; (11):27-30. PubMed ID: 31620
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pathogenetic rationale for inclusion of vitamin E in combined correction of iron deficiency anemia].
    Kuzdenbaeva RS
    Patol Fiziol Eksp Ter; 2001; (2):25. PubMed ID: 11550365
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative effectiveness of etiopathogenetic therapy in adolescents with destructive pulmonary tuberculosis].
    Pavlova MV; Ivanova lA; Titarenko OT; Perova TL
    Probl Tuberk; 1994; (2):45-6. PubMed ID: 8036221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis].
    Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV
    Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervico-mediastinal lymphadenopathy as a paradoxical response to chemotherapy in pulmonary tuberculosis. A case report.
    Janmeja AK; Das SK
    Respiration; 2003; 70(2):219-20. PubMed ID: 12740523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of bronchial pathology on the results of treatment of pulmonary tuberculosis].
    Shesterina MV; Kim ACh; Agafonnikova KI; Rzhavskov IuV; Barchakhova ZI
    Probl Tuberk; 1974; (8):21-3. PubMed ID: 4409353
    [No Abstract]   [Full Text] [Related]  

  • 49. [Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia].
    Voloshina VV; Fomicheva NI
    Probl Tuberk; 2002; (2):10-2. PubMed ID: 11899794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vitamin B1 metabolism in patients with pulmonary tuberculosis at the time of combined antibacterial therapy].
    Kiselova ES
    Sov Med; 1973 Jul; 36(7):138-9. PubMed ID: 4776691
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparison of several methods of treating pulmonary tuberculosis].
    Garbuz VM
    Klin Med (Mosk); 1972 May; 50(5):112-7. PubMed ID: 4340193
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the dynamics of 17-ketosteroid content in the urine of tuberculous patients treated with antibacterial drugs and prednisolone].
    Tsigel'nik AIa; Volkova KI
    Probl Tuberk; 1965; 43(11):65-71. PubMed ID: 5875737
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nicotinic acid metabolism in patients with pulmonary tuberculosis before therapy and during antibacterial therapy].
    Belozorov PT; Vil'nianskiĭ LI; Miroshnikova VI
    Probl Tuberk; 1967; 45(4):55-9. PubMed ID: 5606806
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapeutic failure despite sensitive germs].
    Zierler W
    Wien Med Wochenschr; 1968 Oct; 118(43):921-3. PubMed ID: 4973922
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of antioxidant therapy on lipid peroxidation in patients with acute and protracted pneumonia].
    Borovkova MS; Mashchakevich II
    Klin Med (Mosk); 1988 Dec; 66(12):62-4. PubMed ID: 3230853
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of rheopulmonography in assessing the effectiveness of pathogenetic agents in the combined treatment of pulmonary tuberculosis patients].
    Skiba VP
    Probl Tuberk; 1986; (1):30-2. PubMed ID: 3960837
    [No Abstract]   [Full Text] [Related]  

  • 57. [The state of metabolic processes in patients with pulmonary tuberculosis under hormonal and antibacterial therapy].
    Litvin LM; Chertkova MA; Kharakter ZhZ
    Probl Tuberk; 1968; 46(5):34-41. PubMed ID: 5708497
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinico-biomedical characteristics in manifestations of drug intolerance in patients with pulmonary tuberculosis].
    Sergeev IS; Ignatova AV
    Sov Med; 1973 Jul; 36(7):35-9. PubMed ID: 4776705
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antimycobacterial therapy before results of the antibiogram: importance of multiple combinations to improve the prognosis of cavitary pulmonary tuberculosis. Clinico-statistical study].
    Lukinovich N; Robotti E; Bettini L
    G Ital Mal Torace; 1967; 21(6):283-94. PubMed ID: 5616373
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current socioepidemiologic and clinico-pathogenetic aspects of pulmonary tuberculosis in the Republic of Moldova].
    Sain DO; Iavorskii KM; Emel'ianov OS; Bolotnikova VA; Brumar' AG
    Probl Tuberk; 1997; (1):17-9. PubMed ID: 9162912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.